Back

High-sensitivity cardiac troponin and the effect of finerenone in patients with heart failure and mildly reduced or preserved ejection fraction: a prespecified analysis of FINEARTS-HF

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Personalised therapy in heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Shingo Matsumoto

Tokai University, Tokyo (Japan)

4 More presentations in this session

Presentation thumbnail
Beyond the broken heart: a comprehensive review and meta-analysis on effective management strategies for Takotsubo cardiomyopathy
Mr H. Phan Huu (Ho Chi Minh, VN)
Abstract Slides
Presentation thumbnail
Comparative effectiveness of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: a comprehensive Bayesian network meta-analysis with intervention ranking
Doctor I. Khalil (Dhaka, BD)
Abstract Slides
Presentation thumbnail
Guideline-directed medical therapy use in patients with incident comorbid heart failure and chronic kidney disease (The CaRe Study)
Associate Professor G. Savarese (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Efficacy and safety of rapid up-titration of medical therapies for heart failure by ischemic and non-ischemic etiologies: an analysis of STRONG-HF
Doctor R. Aggarwal (Boston, US)
Abstract Slides

Access the full session

Session thumbnail
Personalised therapy in heart failure
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Presentation
Audience Q&A
thumbnail
Congress Presentation
Did we forget ARNI in the era of SGLTi?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources